Table 2.
Open in new tab

Prevalence ratios for erectile dysfunction by CVH score at baseline

Low CVHModerate CVHHigh CVHPer 1-point higher CVH score
PRPR (95% CI)PR (95% CI)PR (95% CI)
Unadjusted1 (reference group)0.72 (0.63, 0.81)*0.57 (0.41, 0.79)*0.92 (0.89, 0.94)*
Model 21 (reference group)0.72 (0.64, 0.82)*0.58 (0.42, 0.81)*0.92 (0.90, 0.95)*
Model 31 (reference group)0.75 (0.66, 0.84)*0.68 (0.49, 0.94)*0.93 (0.91, 0.96)*
Low CVHModerate CVHHigh CVHPer 1-point higher CVH score
PRPR (95% CI)PR (95% CI)PR (95% CI)
Unadjusted1 (reference group)0.72 (0.63, 0.81)*0.57 (0.41, 0.79)*0.92 (0.89, 0.94)*
Model 21 (reference group)0.72 (0.64, 0.82)*0.58 (0.42, 0.81)*0.92 (0.90, 0.95)*
Model 31 (reference group)0.75 (0.66, 0.84)*0.68 (0.49, 0.94)*0.93 (0.91, 0.96)*

Model 2 includes FMD score. Model 3 includes FMD score, age, study center, education, heavy drinking, diagnosis of chronic illness: kidney or liver disease, emphysema, cancer (including prostate cancer), CES-D score, use of antidepressant medication, and use of beta-blocker medication. Abbreviations: CES-D, center for epidemiologic studies depression score; CI, confidence interval; CVH, cardiovascular health; FMD, flow-mediated dilation; PR, prevalence ratio. *P ≤ 0.01.

Table 2.
Open in new tab

Prevalence ratios for erectile dysfunction by CVH score at baseline

Low CVHModerate CVHHigh CVHPer 1-point higher CVH score
PRPR (95% CI)PR (95% CI)PR (95% CI)
Unadjusted1 (reference group)0.72 (0.63, 0.81)*0.57 (0.41, 0.79)*0.92 (0.89, 0.94)*
Model 21 (reference group)0.72 (0.64, 0.82)*0.58 (0.42, 0.81)*0.92 (0.90, 0.95)*
Model 31 (reference group)0.75 (0.66, 0.84)*0.68 (0.49, 0.94)*0.93 (0.91, 0.96)*
Low CVHModerate CVHHigh CVHPer 1-point higher CVH score
PRPR (95% CI)PR (95% CI)PR (95% CI)
Unadjusted1 (reference group)0.72 (0.63, 0.81)*0.57 (0.41, 0.79)*0.92 (0.89, 0.94)*
Model 21 (reference group)0.72 (0.64, 0.82)*0.58 (0.42, 0.81)*0.92 (0.90, 0.95)*
Model 31 (reference group)0.75 (0.66, 0.84)*0.68 (0.49, 0.94)*0.93 (0.91, 0.96)*

Model 2 includes FMD score. Model 3 includes FMD score, age, study center, education, heavy drinking, diagnosis of chronic illness: kidney or liver disease, emphysema, cancer (including prostate cancer), CES-D score, use of antidepressant medication, and use of beta-blocker medication. Abbreviations: CES-D, center for epidemiologic studies depression score; CI, confidence interval; CVH, cardiovascular health; FMD, flow-mediated dilation; PR, prevalence ratio. *P ≤ 0.01.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close